Urinary kallikrein activity, renal hemodynamics, and electrolyte handling during chronic beta blockade with propranolol in hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007610:Kallikreins / Q000652:urine*; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D010953:Plasma Volume / Q000187:drug effects; D011433:Propranolol / Q000627:therapeutic use*; D011897:Random Allocation; D012079:Renal Circulation / Q000187:drug effects*; D012084:Renin-Angiotensin System / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D004299:Dopamine beta-Hydroxylase; D007610:Kallikreins